Second Genome to Present Big Data Analytics Capabilities at the Microbiome Data Congress

June 9, 2021, Brisbane, Calif

Read More

Second Genome to Present at the Jefferies Microbiome-Based Therapeutics Summit

April 15, 2021, Brisbane, Calif

Read More

Second Genome Appoints Dr. Susannah Cantrell to Chief Business Officer and Dr. Preeti Gupta Lal to Chief Scientific Officer

January 25, 2021, Brisbane, CA

Read More

Second Genome To Present Biomarker Data in Oncology at Keystone Symposium

January 19, 2021, South San Francisco, CA

Read More

Second Genome To Present at Biotech Showcase Digital 2021 Conference

January 11, 2021, South San Francisco, CA

Read More

Gilead Sciences and Second Genome Announce Strategic Collaboration in Biomarker and Inflammatory Bowel Disease Drug Discovery

April 6, 2020, Foster City, CA & South San Francisco, CA

Read More

FORTUNE and Great Place to Work Name Second Genome a "Top 10 Best Workplace in Biopharma"

April 10, 2019, South San Francisco, CA

Read More

Second Genome Expands Development of CNS Platform to Validate Microbial Products as Therapeutics for Autism Spectrum Disorder

March 26, 2019, South San Francisco

Read More